PHOENIX, June 26 /PRNewswire-FirstCall/ -- FORTUNE Small Business announced today that Matrixx Initiatives, Inc. has been ranked 68th on the sixth annual FSB 100 list of the fastest growing small companies in America. Matrixx also earned the #1 spot on the list of Top 25 companies by revenue per employee. The list, which is comprised of public companies, appears in the July/August issue of FORTUNE Small Business and is available at FSB.com.
Carl J. Johnson, President and Chief Executive Officer of Matrixx Initiatives, said, "We are pleased to be recognized as one of America's fastest growing companies. This ranking supports our mission of being a high growth consumer healthcare company that provides unique products that consumers value. We remain focused on growing the Zicam brand and developing innovative products to further our growth."
To compile the sixth annual list, FORTUNE Small Business asked financial research firm Zacks to rank public companies with revenues less than $200 million and a stock price of more than $1, based on their percentage growth in earnings, revenue, and stock performance over the past three years. Banks and real estate firms were excluded.
About Matrixx Initiatives, Inc.
Matrixx Initiatives, Inc. is engaged in the development, manufacture and marketing of over-the-counter healthcare products that utilize innovative drug delivery systems. Zicam, LLC, its wholly-owned subsidiary, produces, markets and sells Zicam(R) products in the cough and cold category, and recently launched a new brand, Nasal Comfort(TM), for nasal health. The Company's flagship product, Zicam Cold Remedy nasal gel, is a patented, homeopathic remedy that has been clinically proven to reduce the duration and severity of the common cold. In studies published in the October 2000 issue of ENT -- Ear, Nose and Throat Journal, and separately in the January 2003 issue of QJM: An International Journal of Medicine, the Zicam Cold Remedy product was shown to reduce the duration of the common cold. The Company also manufactures and markets a full line of Zicam brand pharmaceuticals, including Zicam Cold Remedy Chewables(TM); Zicam Cold Remedy Oral Mist(TM); Zicam Cold Remedy RapidMelts(TM); Zicam Allergy Relief; Zicam Cold Remedy Swabs(TM); Zicam Kids Size Cold Remedy Swabs(TM); Zicam Extreme Congestion Relief; Zicam Sinus Relief; Zicam Nasal Moisturizer, as well as seven Zicam Cough Mist(TM) products and four Zicam Cold & Flu relief items. For more information regarding Matrixx products, go to http://www.zicam.com/. To find out more about Matrixx Initiatives, Inc. , visit our website at http://www.matrixxinc.com/. For additional information, contact William Hemelt, Chief Financial Officer, 602-385-8888, or Bill Barba, Manager of Investor Relations, at 602-385-8881. Matrixx is located at 4742 N. 24th Street, Suite 455, Phoenix, Arizona 85016.
